MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...
Hologic HOLX is set to release fourth-quarter fiscal 2025 results on Nov. 3, after the closing bell. The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share (EPS) suggests an 8.9% ...
Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP profit of $1.04 per share was 5.4% below analysts’ consensus estimates. Is ...
Medical technology company Hologic (NASDAQ:HOLX) reported Q2 CY2025 results , with sales up 1.2% year on year to $1.02 billion. The company expects next quarter’s revenue to be around $1.04 billion, ...
Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results